Lithium Carbonate Tablet, Extended Release
Product Images NDC 0054-0021

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Lithium Carbonate (NDC 0054-0021). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fpl-bl-300mg-100tab-05.jpg (Fpl Bl 300mg 100tab 05)

Fpl-bl-300mg-100tab-05.jpg (Fpl Bl 300mg 100tab 05)
Lithium Carbonate Extended-release Tablets USP 300 mg label with the NDC 0054-0021-25. The label displays 100 tablets, with usage and storage instructions, and warnings to see the package insert. It is distributed by West-Ward Pharmaceuticals Corp., Eatontown, NJ. The label includes a barcode and specifies that the product is prescription only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.